Clinical outcomes in U.S. infants with cystic fibrosis from 2001 to 2012.

Specific PHGKB|HLBS|PHGKB

Lung Diseases

- HLBS-PopOmics -

What's New

Last Posted: Oct 04, 2018

---

• Clinical outcomes in U.S. infants with cystic fibrosis from 2001 to 2012.  
  Hoch Heather et al. Pediatric pulmonology 2018 Sep
• Emerging Insights into the Occupational Mycobiome.  
  Green Brett J et al. Current allergy and asthma reports 2018 Sep 18(11) 62
• Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.  
  Klarin Derek et al. Nature genetics 2018 Oct
• Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).  
  et al. Atherosclerosis 2018 Oct 277234-255
• Precision/Personalized Medicine in Allergic Diseases and Asthma.  
  Kucuksezer Umut Can et al. Archivum immunologiae et therapiae experimentalis 2018 Sep
• Sarcoidosis: proteomics and new perspectives for improving personalized medicine.  
  Landi Claudia et al. Expert review of proteomics 2018 Sep 1-7
• Using clinical and genetic data to predict pulmonary hypertension in bronchopulmonary dysplasia.  
  Trittmann J K et al. Acta paediatrica (Oslo, Norway : 1992) 2018 Sep
• Cost-Effectiveness and Budget Impact of Lumacaftor/Ivacaftor in the Treatment of Cystic Fibrosis.  
  Vadagam Pratyusha et al. Journal of managed care & specialty pharmacy 2018 Oct 24(10) 987-997
• Cystic fibrosis in the era of precision medicine.  
  Paranjape Shruti M et al. Paediatric respiratory reviews 2018 Jan 2564-72
• Direct health-care costs for children diagnosed with genetic diseases are significantly higher than for children with other chronic diseases.  
  Marshall Deborah A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Sep
• Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a 6-year evaluation.  
  Holtkamp Kim C A et al. Journal of community genetics 2018 Sep
• Screening for gene mutations in central nervous system metastases of non-small-cell lung cancer.  
  Nicos Marcin et al. Brain pathology (Zurich, Switzerland) 2018 28(2) 295-297
• Solving the genome puzzle: With advances in gene technology helping to diagnose very rare diseases, has the new era of personalised medicine finally arrived?  
  L Geddes, The Guardian, September 21, 2018
• Towards personalised medicine in lung and thymus neuroendocrine tumours.  
  Pelosi Giuseppe et al. The Lancet. Oncology 2017 18(12) 1563-1565
• Training the 21st century cancer epidemiologist  
  T Lam et al, J Cancer Education, September 2018